Glassman Wealth Services - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.

Quarter-by-quarter ownership
Glassman Wealth Services ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,146
-13.0%
550.0%0.00%
Q2 2023$1,317
+27.2%
550.0%0.00%
Q1 2023$1,035
+18.2%
550.0%0.00%
Q4 2022$876
-12.4%
55
-31.2%
0.00%
Q3 2022$1,0000.0%80
-7.0%
0.00%
Q2 2022$1,000
-80.0%
86
-61.1%
0.00%
-100.0%
Q1 2022$5,0000.0%221
+14.5%
0.00%0.0%
Q4 2021$5,000
+150.0%
193
+91.1%
0.00%
Q3 2021$2,0000.0%101
+53.0%
0.00%
Q2 2021$2,000
-75.0%
66
-79.6%
0.00%
-100.0%
Q1 2021$8,000
-71.4%
324
-38.2%
0.00%
-33.3%
Q4 2020$28,000
+833.3%
524
+706.2%
0.00%
+200.0%
Q3 2020$3,0000.0%650.0%0.00%0.0%
Q2 2020$3,0000.0%650.0%0.00%0.0%
Q1 2020$3,0000.0%65
+10.2%
0.00%0.0%
Q4 2019$3,000
+50.0%
59
+7.3%
0.00%0.0%
Q3 2019$2,0000.0%55
-12.7%
0.00%0.0%
Q2 2019$2,000
-99.5%
63
-99.6%
0.00%
-99.4%
Q1 2019$404,000
+66.3%
15,055
+0.4%
0.18%
+34.4%
Q4 2018$243,000
-21.9%
15,0000.0%0.13%
-8.4%
Q3 2018$311,000
+35.8%
15,0000.0%0.14%
+25.4%
Q2 2018$229,00015,000
+136263.6%
0.11%
Q1 2018$0
-100.0%
11
-92.1%
0.00%
-100.0%
Q3 2017$5,000
+25.0%
1400.0%0.00%0.0%
Q2 2017$4,000
-20.0%
1400.0%0.00%0.0%
Q1 2017$5,000
+25.0%
1400.0%0.00%0.0%
Q4 2016$4,0000.0%1400.0%0.00%0.0%
Q3 2016$4,0001400.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders